Cited by 162

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Therapeutic Effects of Transplanted Exosomes Containing miR-29b to a Rat Model of Alzheimer’s Disease

Jahangard, Yavar, Monfared, Hamideh, Moradi, Arman, Zare, Meysam, Mirnajafi-Zadeh, Javad, Mowla, Seyed Javad·2020·Frontiers in Neuroscience

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2020.00564

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes., Nat. Biotechnol., 29, 341, 10.1038/nbt.1807 · DOI · Paper page
  2. Andaloussi, 2013, Extracellular vesicles: biology and emerging therapeutic opportunities., Nat. Rev. Drug Discov., 12, 347, 10.1038/nrd3978 · DOI · Paper page
  3. Chen, 2018, RNA interference-based therapy and its delivery systems., Cancer Metastasis Rev., 37, 107, 10.1007/s10555-017-9717-6 · DOI
  4. Chow, 2010, An overview of APP processing enzymes and products., Neuromol. Med., 12, 1, 10.1007/s12017-009-8104-z · DOI · Paper page
  5. Drachman, 2014, The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimer’s disease., Alzheimer’s Dement., 10, 372, 10.1016/j.jalz.2013.11.003 · DOI · Paper page
  6. Femminella, 2015, The emerging role of microRNAs in Alzheimer’s disease., Front. Physiol., 6, 10.3389/fphys.2015.00040 · DOI
  7. Gebert, 2018, Regulation of microRNA function in animals., Nat. Rev. Mol. Cell Biol., 20, 21, 10.1038/s41580-018-0045-7 · DOI · Paper page
  8. Geng, 2010, Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats., Biol. Pharm. Bull., 33, 836, 10.1248/bpb.33.836 · DOI
  9. Gnecchi, 2016, Paracrine mechanisms of mesenchymal stem cells in tissue repair., Mesenchymal Stem Cells, 1416, 123, 10.1007/978-1-4939-3584-0_7 · DOI
  10. György, 2011, Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles., Cell. Mol. Life Sci., 68, 2667, 10.1007/s00018-011-0689-3 · DOI
  11. Hardy, 2002, The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics., Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  12. Hébert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/β-secretase expression., Proc. Natl. Acad. Sci. U.S.A., 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
  13. Kasza, 2017, Studies for improving a rat model of Alzheimer’s disease: icv administration of well-characterized β-amyloid 1-42 oligomers induce dysfunction in spatial memory., Molecules, 22, 10.3390/molecules22112007 · DOI
  14. Kole, 2011, miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis., Genes Dev., 25, 125, 10.1101/gad.1975411 · DOI
  15. Li, 2012, Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis., Stem Cells Dev., 22, 845, 10.1089/scd.2012.0395 · DOI
  16. Lippi, 2011, Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology., J. Cell Biol., 194, 889, 10.1083/jcb.201103006 · DOI
  17. Liu, 2015, Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse., Sci. Rep., 5, 10.1038/srep17543 · DOI
  18. Lu, 2017, Exosome-based small RNA delivery: progress and prospects., Asian J. Pharm. Sci., 13, 1, 10.1016/j.ajps.2017.07.008 · DOI · Paper page
  19. Mathiyalagan, 2017, Exosomes-based gene therapy for microRNA delivery., Methods Mol. Biol., 1521, 139, 10.1007/978-1-4939-6588-5_9 · DOI
  20. Morel, 2015, Cognitive impairment and morphological changes in the dorsal hippocampus of very old female rats., Neuroscience, 303, 189, 10.1016/j.neuroscience.2015.06.050 · DOI
  21. Mu, 2011, Adult hippocampal neurogenesis and its role in Alzheimer’s disease., Mol. Neurodegener., 6, 10.1186/1750-1326-6-85 · DOI · Paper page
  22. Nunez-Iglesias, 2010, Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer’s disease cortex reveals altered miRNA regulation., PLoS One, 5, 10.1371/journal.pone.0008898 · DOI
  23. Paxinos, 2006, The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition.
  24. Pearson-Leary, 2012, Intrahippocampal administration of amyloid-β 1-42 oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism., J. Alzheimer’s Dis., 30, 413, 10.3233/jad-2012-112192 · DOI
  25. Pereira, 2016, Recombinant pre-miR-29b for Alzheimer ‘s disease therapeutics., Sci. Rep., 6, 10.1038/srep19946 · DOI
  26. Pitts, 2018, Barnes maze procedure for spatial learning and memory in mice., Bio Protoc., 8, 10.21769/BioProtoc.2744 · DOI
  27. Rani, 2015, Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications., Mol. Ther., 23, 812, 10.1038/mt.2015.44 · DOI
  28. Record, 2011, Exosomes as intercellular signalosomes and pharmacological effectors., Biochem. Pharmacol., 81, 1171, 10.1016/j.bcp.2011.02.011 · DOI
  29. Roshan, 2014, Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice., RNA, 20, 1287, 10.1261/rna.044008.113 · DOI
  30. Scott, 2007, Dementia syndromes: evaluation and treatment., Expert Rev. Neurother., 7, 407, 10.1586/14737175.7.4.407 · DOI
  31. Selkoe, 2001, Alzheimer’s disease: genes, proteins, and therapy., Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
  32. Shioya, 2010, Aberrant microRNA expression in the brains of neurodegenerative diseases: miR−29a decreased in Alzheimer disease brains targets neurone navigator 3., Neuropathol. Appl. Neurobiol., 36, 320, 10.1111/j.1365-2990.2010.01076.x · DOI · Paper page
  33. Simons, 2009, Exosomes–vesicular carriers for intercellular communication., Curr. Opin. Cell Biol., 21, 575, 10.1016/j.ceb.2009.03.007 · DOI
  34. Sokolova, 2011, Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy., Colloids Surf. B Biointerf., 87, 146, 10.1016/j.colsurfb.2011.05.013 · DOI
  35. Soleimani, 2008, A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow., Nat. Protoc., 4, 102, 10.1038/nprot.2008.221 · DOI
  36. Soo, 2012, Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells., Immunology, 136, 192, 10.1111/j.1365-2567.2012.03569.x · DOI
  37. Théry, 2009, Membrane vesicles as conveyors of immune responses., Nat. Rev. Immunol., 9, 581, 10.1038/nri2567 · DOI
  38. Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells., Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
  39. Wang, 2015, Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele., Stem Cells Transl. Med., 4, 659, 10.5966/sctm.2014-0296 · DOI
  40. Yamashita, 2018, Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application., Biol. Pharm. Bull., 41, 835, 10.1248/bpb.b18-00133 · DOI
  41. Yang, 2015, MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo., Mol. Med. Rep., 12, 3081, 10.3892/mmr.2015.3728 · DOI
  42. Zhuang, 2011, Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain., Mol. Ther., 19, 1769, 10.1038/mt.2011.164 · DOI · Paper page
  43. Zong, 2011, miR-29c regulates BACE1 protein expression., Brain Res., 1395, 108, 10.1016/j.brainres.2011.04.035 · DOI · Paper page
  44. Zong, 2015, miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer’s disease., Brain Res., 1624, 95, 10.1016/j.brainres.2015.07.022 · DOI

Cited by

Sorted by citations

Metadata

Authors
Jahangard, Y., Monfared, H., Moradi, A., Zare, M., Mirnajafi-Zadeh, J., & Mowla, S. J.
Venue
Frontiers in Neuroscience
Published
2020-06-18
Volume
14
ISSN
1662-453X
Cited by
162
References
8

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review